Showing results (1-10 of 616) with videos related to
Sort By:
Pageof 62
Current Oncology (Toronto, Ont.)|December 22, 2022
Integrating Systematic Reviews into Supportive Care Trial Design: The Rethinking Clinical Trials (REaCT) ProgramBader Alshamsan, Brian Hutton, Michelle Liu, et al.Current Oncology (Toronto, Ont.)|October 22, 2021
The Rethinking Clinical Trials (REaCT) Program. A Canadian-Led Pragmatic Trials Program: Strategies for Integrating Knowledge Users into Trial DesignDeanna Saunders, Michelle Liu, Lisa Vandermeer, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 21, 2022
Symptomatic skeletal-related events in patients receiving longer term bone-modifying agents for bone metastases from breast and castration resistant prostate cancersMashari Alzahrani, Carol Stober, Michelle Liu, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 25, 2023
Management of genitourinary symptoms in patients with breast cancer: an updated systematic review of available evidence from randomized trialsParvaneh Fallah, Dianna Wolfe, Brian Hutton, et al.Plos One|July 25, 2018
Randomised feasibility trial to compare three standard of care chemotherapy regimens for early stage triple-negative breast cancer (REaCT-TNBC trial)John Hilton, Carol Stober, Sasha Mazzarello, et al.Breast Cancer Research and Treatment|January 7, 2016
Choice of study endpoint significantly impacts the results of breast cancer trials evaluating chemotherapy-induced nausea and vomitingTerry Ng, Sasha Mazzarello, Zhou Wang, et al.Current Oncology (Toronto, Ont.)|July 21, 2021
Does the Time of Day at Which Endocrine Therapy Is Taken Affect Breast Cancer Patient Outcomes?Ana-Alicia Beltran-Bless, Lisa Vandermeer, Mohammed F K Ibrahim, et al.Journal of Bone Oncology|December 9, 2020
Real-world practice patterns and attitudes towards de-escalation of bone-modifying agents in patients with bone metastases from breast and prostate cancer: A physician surveyMashari AlZahrani, Mark Clemons, Lisa Vandermeer, et al.Journal of Oncology Practice|September 22, 2016
Novel Methodology for Comparing Standard-of-Care Interventions in Patients With CancerJohn Hilton, Sasha Mazzarello, Dean Fergusson, et al.Journal of Oncology Practice|November 14, 2014
Are Physicians Choosing Wisely When Imaging for Distant Metastases in Women With Operable Breast Cancer?Demetrios Simos, Brian Hutton, Mark ClemonsPageof 62